| 000 | 01904nam a2200349 i 4500 | ||
|---|---|---|---|
| 008 | 200603s2019 enka b 001 0 eng d | ||
| 020 |
_a9780367389734 _qhardback/paperback _cRM298.10(PTSL) |
||
| 040 |
_aUKM _erda |
||
| 090 |
_aRM301.3.G45 _bC639 |
||
| 245 | 0 | 0 |
_aComparative genomics and proteomics in drug discovery / _c editor by John Parrington & Kevin Coward. |
| 264 | 1 |
_aLondon : _b CRC Press, _c 2019. |
|
| 264 | 4 | _c©2019. | |
| 300 |
_axii, 182 pages : _b illustrations ; _c 24 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | _aComparative genomics and drug discovery in trypanosomatids -- The practical implications of comparative kinetoplastid genomics -- The relevance of host genes in malaria -- Nicotinic acetylcholine receptors as drug/chemical targets, contributions from comparative genomics, forward and reverse genetics -- Discovery of novel sodium channel inhibitors : a gene family-based approach --'Omics' in translational medicine : are they lost in translation? -- Drug-target discovery in silico : using the Web to identify novel molecular targets for drug action | ||
| 650 | 0 | _aPharmacogenomics. | |
| 650 | 0 | _aProteomics. | |
| 650 | 0 | _aDrug development. | |
| 650 | 0 | _aPharmacognosy. | |
| 700 | 1 |
_aParrington, John, _e editor. |
|
| 700 | 1 |
_aCoward, Kevin, _d1969-, _e editor. |
|
| 907 |
_a.b16804570 _b2020-08-11 _c2020-06-03 |
||
| 942 |
_c01 _n0 _kRM301.3.G45 C639 |
||
| 949 | _o101007060 | ||
| 990 | _aros/jm | ||
| 991 | _aInstitut Biologi Sistem | ||
| 998 |
_at _b2020-06-03 _cm _da _feng _genk _y0 _z.b16804570 |
||
| 999 |
_c647887 _d647887 |
||